Moneygram (MGI) Down in Light Trading for May 13

Equities Staff  |

Moneygram International Inc. (NASDAQ:MGI) stock was among today's market movers, concluding trading down 2.79% to $9.42 on May 13.

2,247,867 shares were traded today in comparison to the 30-day daily average of 3,925,620 shares.

The company's stock has fallen 22.81% so far in 2022.

Moneygram shares have fluctuated between $5.06 and $12.36 over the past twelve months.

For technical charts, analysis, and more on Moneygram visit the company profile.

About Moneygram International Inc.

MoneyGram is a global leader in cross-border P2P payments and money transfers. Its consumer-centric capabilities enable family and friends to quickly and affordably send money in more than 200 countries and territories, with 90 now digitally enabled.

To get more information on Moneygram International Inc. and to follow the company's latest updates, you can visit the company's profile page here: Moneygram International Inc.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement

Market Movers

Sponsored Financial Content